USDA approves new oral Bordetella vaccine for dogsFebruary 1, 2026The oral vaccine is reportedly the first USDA-licensed ½ mL oral Bordetella bronchiseptica vaccine for dogs and is designed to “reduce adverse reactions by removing unwanted protein and debris and to improve patient comfort.”
SPONSORED CONTENTWhere unique needs meet innovative scienceFind precise, innovative solutions for your patients' unique needs + Learn More
USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an anti–IL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
